Publications by authors named "Volker Hanf"

Claim this Profile
I
Invasive disease-free and overall survival after (neo)adjuvant chemotherapy in postmenopausal patients with hormone receptor-positive, HER2-negative early breast cancer treated with upfront letrozole: Experiences from the phase IV PreFace trial.
Milena Beierlein, Lothar Häberle, Naiba Nabieva, Nicolai Maass, Bahriye Aktas, Volker Hanf

Int J Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective validation of the prognostic and predictive impact of uPA/PAI-1 in early breast cancer.
Vanessa Wieder, Julia Engel, Kathleen Eichstädt, Sandy Kaufhold, Marcus Bauer, Volker Hanf

Breast Cancer Res Treat· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experiences and expectations of advance directives in gynecological cancer patients (the NOGGO-expression X study).
Melisa Guelhan Inci, Ebru Ilter, Eva Roser, Desislava Dimitrova, Reema Kofiah, Volker Hanf

Int J Gynecol Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and predictive impact of NOTCH1 in early breast cancer.
Julia Engel, Vanessa Wieder, Marcus Bauer, Sandy Kaufhold, Kathrin Stückrath, Volker Hanf

Breast Cancer Res Treat· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Prognostic and predictive impact of NOTCH1 in early breast cancer.
Julia Engel, Vanessa Wieder, Marcus Bauer, Sandy Kaufhold, Kathrin Stückrath, Volker Hanf

Breast Cancer Res Treat· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of selection criteria of current adjuvant endocrine therapy trials NATALEE and monarchE in postmenopausal HRpos/HER2neg breast cancer patients treated with upfront letrozole.
Peter A Fasching, Carolin C Hack, Naiba Nabieva, Nicolai Maass, Bahriye Aktas, Volker Hanf

Eur J Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Follow-up and Safety of Patients after an Upfront Therapy with Letrozole for Early Breast Cancer in Routine Clinical Care - The PreFace Study.
Carolin C Hack, Nicolai Maass, Bahriye Aktas, Sherko Kümmel, Christoph Thomssen, Volker Hanf

Geburtshilfe Frauenheilkd· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Long-term Follow-up and Safety of Patients after an Upfront Therapy with Letrozole for Early Breast Cancer in Routine Clinical Care - The PreFace Study.
Carolin C Hack, Nicolai Maass, Bahriye Aktas, Sherko Kümmel, Christoph Thomssen, Volker Hanf

Geburtshilfe Frauenheilkd· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of Targeted Axillary Dissection After Neoadjuvant Therapy in Patients With Node-Positive Breast Cancer.
Sherko Kuemmel, Joerg Heil, Simona Bruzas, Elisabeth Breit, Dorothea Schindowski, Volker Hanf

JAMA Surg· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endometrial Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry Number 032/034-OL, September 2022) - Part 2 with Recommendations on the Therapy of Precancerous Lesions and Early-stage Endometrial Cancer, Surgical Therapy, Radiotherapy and Drug-based Therapy, Follow-up Care, Recurrence and Metastases, Psycho-oncological Care, Palliative Care, Patient Education, and Rehabilitative and Physiotherapeutic Care.
Günter Emons, Eric Steiner, Dirk Vordermark, Christoph Uleer, Kerstin Paradies, Volker Hanf

Geburtshilfe Frauenheilkd· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endometrial Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry Number 032/034-OL, September 2022). Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors of Endometrial Cancer, Geriatric Assessment and Supply Structures.
Günter Emons, Eric Steiner, Dirk Vordermark, Christoph Uleer, Kerstin Paradies, Volker Hanf

Geburtshilfe Frauenheilkd· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant Docetaxel in Node-Negative Breast Cancer Patients: A Randomized Trial of AGO-Breast Study Group, German Breast Group, and EORTC-Pathobiology Group.
Christoph Thomssen, Martina Vetter, Eva J Kantelhardt, Christoph Meisner, Marcus Schmidt, Volker Hanf

Cancers (Basel)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PIK3CA-mutations in breast cancer.
Kristin Reinhardt, Kathrin Stückrath, Carolin Hartung, Sandy Kaufhold, Christoph Uleer, Volker Hanf

Breast Cancer Res Treat· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Prospective, Multicenter Registry Study to Evaluate the Clinical Feasibility of Targeted Axillary Dissection (TAD) in Node-positive Breast Cancer Patients.
Sherko Kuemmel, Joerg Heil, Anna Rueland, Christine Seiberling, Hakima Harrach, Volker Hanf

Ann Surg· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of Tumour-Infiltrating Lymphocytes in an Unselected Cohort of Breast Cancer Patients.
Kathleen Schüler, Daniel Bethmann, Sandy Kaufhold, Carolin Hartung, Kathrin Stückrath, Volker Hanf

Diagnostics (Basel)· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of SARS-CoV-2 in Pregnant Women Assessed by RT-PCR in Franconia, Germany: First Results of the SCENARIO Study (SARS-CoV-2 prEvalence in pregNAncy and at biRth In FrancOnia).
Alexander Hein, Sven Kehl, Lothar Häberle, Carsten Tiemann, Rebecca Peuker, Volker Hanf

Geburtshilfe Frauenheilkd· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying High-Risk Triple-Negative Breast Cancer Patients by Molecular Subtyping.
Carolin Hartung, Martin Porsch, Kathrin Stückrath, Sandy Kaufhold, Martin S Staege, Volker Hanf

Breast Care (Basel)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AGO Recommendations for the Surgical Therapy of the Axilla After Neoadjuvant Chemotherapy: 2021 Update.
Michael Friedrich, Thorsten Kühn, Wolfgang Janni, Volkmar Müller, Maggie Banys-Pachulowski, Volker Hanf

Geburtshilfe Frauenheilkd· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: AGO Recommendations for the Surgical Therapy of the Axilla After Neoadjuvant Chemotherapy: 2021 Update.
Michael Friedrich, Thorsten Kühn, Wolfgang Janni, Volkmar Müller, Maggie Banys-Paluchowski, Volker Hanf

Geburtshilfe Frauenheilkd· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Is the Quality Guideline of Care Delivery of Preterm and Mature Infants (QFR-RL) of the Federal Joint Committee (G-BA) a Quality Risk? - An Analysis of the Fulfillment Rate and the Consequences for Care Delivery to Other IC Patients and Imminent Premature Infants at a Regional Network of Perinatal Centers].
Markus Kleeberg, Matthias Beckmann, Christoph Fusch, Volker Hanf, Franz Kainer

Z Geburtshilfe Neonatol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LION-PAW (lymphadenectomy in ovarian neoplasm) sexual function assessment: a prospective sub-study of the LION trial.
Annette Hasenburg, Jalid Sehouli, Bjoern Lampe, Alexander Reuss, Barbara Schmalfeld, Volker Hanf

Int J Gynecol Cancer· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2020.
Nina Ditsch, Michael Untch, Cornelia Kolberg-Liedtke, Christian Jackisch, David Krug, Volker Hanf

Breast Care (Basel)· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2019.
Nina Ditsch, Michael Untch, Marc Thill, Volkmar Müller, Wolfgang Janni, Volker Hanf

Breast Care (Basel)· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2019.
Marc Thill, Christian Jackisch, Wolfgang Janni, Volkmar Müller, Ute-Susann Albert, Volker Hanf

Breast Care (Basel)· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Specific allelic variants of SNPs in the and genes are associated with earlier tumor onset and progression in Caucasian breast cancer patients.
Marcus Bauer, Eva Johanna Kantelhardt, Thorsten Stiewe, Andrea Nist, Marco Mernberger, Volker Hanf

Oncotarget· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis